Rosetta Genomics (NASDAQ: ROSG) reported Q4 EPS of ($0.14). Revenue for the quarter came in at $3.6 million, versus $698 thousand reported last year.

For earnings history and earnings-related data on Rosetta Genomics (ROSG) click here.